Low‐level viremia in hepatitis b patients on antiviral treatment: Can we ignore it?
Albert D. Min – 24 April 2017
Donor safety in living donor liver transplantation: The Korean organ transplantation registry study
Jae Geun Lee, Kwang‐Woong Lee, Choon Hyuck David Kwon, Chong Woo Chu, Bong‐Wan Kim, Dong Lak Choi, Young Kyoung You, Dong‐Sik Kim, Yang Won Nah, Koo Jeong Kang, In Soek Choi, Hee Chul Yu, Geun Hong, Ho‐Seong Han, Shin Hwang, Myoung Soo Kim – 21 April 2017 – Major concerns about donor safety cause controversy and limit the use of living donor liver transplantation to overcome organ shortages. The Korean Organ Transplantation Registry established a nationwide organ transplantation registration system in 2014.
Biomarkers and imaging studies to predict portal hypertension and varices
Christine K. Lee – 20 April 2017
Hepatic steatosis after pediatric liver transplant
Emily R. Perito, Tabitha Vase, Rageshree Ramachandran, Andrew Phelps, Kuang‐Yu Jen, Robert H. Lustig, Vickie A. Feldstein, Philip Rosenthal – 20 April 2017 – Hepatic steatosis develops after liver transplantation (LT) in 30% of adults, and nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in nontransplanted children. However, posttransplant steatosis has been minimally studied in pediatric LT recipients. We explored the prevalence, persistence, and association with chronic liver damage of hepatic steatosis in these children.
Liver retransplantation: Recurrent primary sclerosing cholangitis may provide better outcomes
Jennie Choe, David C. Mulligan – 20 April 2017
Biomarkers and imaging studies to predict portal hypertension and varices
Christine K. Lee – 20 April 2017
Treatment of HCV in persons who inject drugs: Treatment as prevention
Jason Grebely, Gregory J. Dore – 20 April 2017
Transplanting patients with active bacterial infection
Elizabeth C. Verna, Marcus R. Pereira – 20 April 2017
Hepatic fibrosis in children and adults
Rebecca G. Wells – 20 April 2017
Significance of measured intraoperative portal vein flows after thrombendvenectomy in deceased donor liver transplantations with portal vein thrombosis
Mark Draoua, Nicole Titze, Amar Gupta, Hoylan T. Fernandez, Michael Ramsay, Giovanna Saracino, Gregory McKenna, Giuliano Testa, Goran B. Klintmalm, Peter T. W. Kim – 20 April 2017 – Adequate portal vein (PV) flow in liver transplantation is essential for a good outcome, and it may be compromised in patients with portal vein thrombosis (PVT). This study evaluated the impact of intraoperatively measured PV flow after PV thrombendvenectomy on outcomes after deceased donor liver transplantation (DDLT).